Authors: AHLERT T SAUERBREI W BASTERT G RUHLAND S BARTIK B SIMIANTONAKI N SCHUMACHER J HACKER B SCHUMACHER M SCHIRRMACHER V

Citation: T. Ahlert et al., TUMOR-CELL NUMBER AND VIABILITY AS QUALITY AND EFFICACY PARAMETERS OFAUTOLOGOUS VIRUS-MODIFIED CANCER VACCINES IN PATIENTS WITH BREAST OR OVARIAN-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1354-1366

Authors: FABBRINI N MESSMORE HL BALBALE S PANZA L RUHLAND S CROSBY T EDWARDS B BIRD ML WEHRMACHER W BRACE L

Citation: N. Fabbrini et al., EX-VIVO HEPARIN LEVELS COMPARED WITH APTT RATIOS IN HEPARINIZED PATIENTS - RESULTS UTILIZING 10 DIFFERENT APTT REAGENTS, Thrombosis and haemostasis, 1997, pp. 1153-1153

Authors: FABBRINI N RUHLAND S MESSMORE HL BIRD ML BALBALE S CROSBY T EDWARDS B WEHRMACHER W BRACE L

Citation: N. Fabbrini et al., SENSITIVITY OF 5 LATEX AGGLUTINATION-TEST KITS FOR D-DIMER AS COMPARED WITH AN ENZYME-IMMUNOASSAY TEST KIT, Thrombosis and haemostasis, 1997, pp. 1789-1789